ProPhase Labs Inc.

NASDAQ: PRPH · Real-Time Price · USD
0.34
-0.02 (-5.03%)
At close: Jun 09, 2025, 3:59 PM

ProPhase Labs Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
678K 1.61M 9.11M 8.41M
Short-Term Investments
n/a 3.13M 8.33M 8.86M
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
5.97M 2M 1.28M 1.07M
Receivables
20.06M 36.31M 37.05M 37.71M
Inventory
1.14M 3.84M 3.98M 4.6M
Other Current Assets
8.76M 540K 2.37M 250K
Total Current Assets
30.64M 47.59M 60.83M 61.32M
Property-Plant & Equipment
11.62M 17.47M 11.35M 10.35M
Goodwill & Intangibles
14.98M 17.56M 14.18M 16.56M
Total Long-Term Assets
32.56M 44.34M 26.82M 27.98M
Total Assets
63.2M 91.93M 87.65M 89.3M
Account Payables
13.72M 9.38M 5.91M 7.03M
Deferred Revenue
1.7M 2.38M 2.5M 2.03M
Short-Term Debt
6.57M n/a 301K 663K
Other Current Liabilities
8.16M 1.79M 2.63M 3.25M
Total Current Liabilities
32.13M 20.86M 16.07M 15.52M
Long-Term Debt
n/a 10.26M 2.4M 10.04M
Other Long-Term Liabilities
22.93M 2M n/a n/a
Total Long-Term Liabilities
23.71M 21.69M 7.94M 15.14M
Total Liabilities
55.85M 42.54M 24.02M 30.67M
Total Debt
24.57M 21.38M 6.96M 14.9M
Common Stock
23K 18K 16K 16K
Retained Earnings
-58.39M -5.03M 11.75M 2.64M
Comprehensive Income
n/a -300K 757K -175K
Shareholders Equity
7.35M 49.38M 63.63M 58.63M
Total Investments
n/a 3.13M 8.33M 8.86M